Funding for this research was provided by:
Bayer HealthCare (NCT02390934)
Received: 30 October 2020
Accepted: 1 February 2021
First Online: 23 February 2021
: The authors declare no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The trial was approved by the local institutional ethical committee of Gustave Roussy, Institut Universitaire du Cancer Toulouse Oncopole and Groupement Hospitalier Est of Bron.